Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment

This publication has 42 references indexed in Scilit:

• Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas
  European Journal Of Cancer, 2004
• Tissue Microarray Validation of Epidermal Growth Factor Receptor and SALL2 in Synovial Sarcoma with Comparison to Tumors of Similar Histology
  The American Journal of Pathology, 2003
• Most Malignant Fibrous Histiocytomas Developed in the Retroperitoneum Are Dedifferentiated Liposarcomas: A Review of 25 Cases Initially Diagnosed as Malignant Fibrous Histiocytoma
  Laboratory Investigation, 2003
• Malignant mixed mesodermal tumours: biology and clinical aspects
  European Journal Of Cancer, 2002
• Molecular characterisation of soft tissue tumours: a gene expression study
  The Lancet, 2002
• Clinicopathologic Analysis of HER-2/neu Immunoexpression among Various Histologic Subtypes and Grades of Osteosarcoma
  Laboratory Investigation, 2001
• Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
  Laboratory Investigation, 2000
• Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours
  Journal of Clinical Pathology, 1999
• Desmoplastic Small Round Cell Tumor
  The American Journal of Surgical Pathology, 1998
• Tissue microarrays for high-throughput molecular profiling of tumor specimens
  Nature Medicine, 1998